Literature Search
The systematic search of case-control studies published from 1990.01.01 to 2022.12.31 identified 998 results. After title and abstract screening, 18 articles were considered potentially relevant. 18 studies (Zou DongMei et al., 2020; Jin Yong et al., 2016; Xiu ShuangLing et al., 2020; Ceng Feng et al., 2022; Zhao Ying et al., 2018; Zhu Bing et al., 2005; Gu QiaoPing et al., 2020; Zhao Yu et al., 2022; Wen HaiZhao et al., 2022; Xiong Jian et al., 2016; Can-Chen Ma et al., 2017; Yu Mor et al., 2020; Chun-Wei Lin et al., 2015; Lidwien Graat-Verboom et al., 2012; Wang Kai et al., 2020; Li HuiLan et al., 2008; Cao Ying et al., 2014; T. S U Z U K I et al., 1997) were included after a full-text review. The selection process is presented in Figure 1.
Study Characteristics
This meta-analysis included 18 case-control studies covering 9078 individuals, which were published between 1990 and 2022, and had clear diagnostic criteria for primary osteoporosis (osteoporosis in older men and postmenopausal osteoporosis) versus secondary osteoporosis. OR,95% CIand SE for the association between BMI and osteoporosis were included in all findings. Two of these papers examined BMI by class (Lidwien Graat-Verboom et al., 2012; Cao Ying et al., 2014). The main characteristics of the included trials are shown in Figure 2.
Quality Assessment
According to NOS criteria, the average score was 7.8 for all included cohort studies, and the score for each trial was seven or above, indicating that all case-control studies were of high quality in this meta-analysis. The scores of the included studies are shown in Figure 2.
BMI and risk factors for osteoporosis in combination with type 2 diabetes
Five case-control studies (Zou DongMei et al., 2020; Jin Yong et al., 2016; Xiu Shuang Ling et al., 2020; Ceng Feng et al., 2022; Zhao Ying et al., 2018) explored the association between BMI and Type 2 diabetes mellitus combined with osteoporosis. The meta-analysis showed that I 2 = 98%. The heterogeneity is large, so the sensitivity analysis uses the method of plural exclusion. They exclude one of the papers (Zhao Ying et al., 2018). The pooling analysis of the remaining four papers shows that BMI is associated with an increased risk of Type 2 diabetes mellitus combined with osteoporosis (OR = 1.92; 95% CI: 1.73–2.21; I 2 = 0%, P < 0.00001; Figure 3). The results showed that low BMI was a risk factor for osteoporosis complicated by type 2 diabetes. After analyzing this literature, the results show that (Zhao Ying et al., 2018; OR=0.85, P=0.045) Low BMI is a risk factor for complications of osteoporosis in patients with type 2 diabetes.
BMI and risk factors for postmenopausal osteoporosis in women
Three case-control studies (Zhu Bing et al., 2005; Gu QiaoPing et al., 2020; Zhao Yu et al., 2022) explored the association between BMI and postmenopausal osteoporosis in women. The meta-analysis showed that I 2 = 87%. The heterogeneity is large, so the sensitivity analysis uses the method of plural exclusion, excluding one of the papers (Zhao Yu et al., 2022). The pooling analysis of the remaining two papers shows that BMI is associated with an increased risk of postmenopausal osteoporosis in women(OR = 0.50; 95% CI: 0.32–0.77; I 2 = 0%, P =0.002; Figure 4). The analysis showed that high BMI is a risk factor for osteoporosis in menopausal women; The results of this analysis of the literature (Zhao Yu et al., 2022; OR=2.252, P=0.0431) suggest that a high BMI is a risk factor for complications of osteoporosis in menopausal women.
BMI and risk factors for primary osteoporosis
Four case-control studies (Xiong Jian et al., 2016; Wen HaiZhao et al., 2022; Cao Ying et al., 2014; T. SUZUKI et al., 1997) explored the association between BMI and risk factors for primary osteoporosis. A total of eight studies were involved in the data. The meta-analysis showed I 2=65%, which is more heterogeneous, so the sensitivity analysis was done by subgroup analysis according to the grade of BMI (low, normal, high), including data from four studies (Xiong Jian et al., 2016; Wen HaiZhao et al., 2022; Cao Ying et al., 2014; T. SUZUKI et al., 1997). The results of the meta-analysis showed that: OR = 0.59; 95% CI: 0.41–0.85; I 2=43%, P = 0.005; The results of the final analysis study showed that low BMI is associated with an increased risk of primary osteoporosis; Figure 5.
Subgroup 2 consisted of two papers with normal BMI, a total of 2 studies data (Cao Ying et al., 2014; T. SUZUKI et al., 1997); meta-analysis results show: I 2 = 90%, heterogeneity is considerable. So, it cannot indicate that normal BMI is related to risk factors for primary osteoporosis, Plural analysis of the literature: Results of a literature (Cao Ying et al., 2014) analysis shows that normal BMI is not a risk factor for primary osteoporosis (OR=1.018, =0.9664); An analysis of the literature (T. SUZUKI et al., 1997) shows that normal BMI is a risk factor for primary osteoporosis (OR=0.46, P<0.05).
Subgroup 3 consisted of two papers with high BMI, a total of 2 studies data (Cao Ying et al., 2014; T. SUZUKI et al., 1997). Meta-analysis results show: I 2 = 62%, heterogeneity is considerable. So, it cannot indicate that high BMI is related to risk factors for primary osteoporosis, Plural analysis of the literature: Results of a literature (Cao Ying et al., 2014) analysis shows that high BMI is not a risk factor for primary osteoporosis (OR=0.897, =0.7874); An analysis of the literature (T. SUZUKI et al., 1997) shows that high BMI is a risk factor for primary osteoporosis (OR=0.18, P<0.001).
BMI and risk factors for glucocorticoid-induced osteoporosis
Two case-control studies (Can-Chen Ma et al., 2017; Yu Mor et al., 2020) explored the association between BMI and glucocorticoid-induced osteoporosis; The results of the meta-analysis showed that: OR = 0.86; 95% CI: 0.82–0.90; I 2= 0%, P <0.00001; The results of the final analysis study showed that patients with regular glucocorticoid use, BMI is a risk factor for osteoporosis. Figure 6.
BMI and risk factors for COPD combined with osteoporosis
Two case-control studies (Chun-Wei Lin et al., 2015; Lidwien Graat-Verboom et al., 2012) explored the association between BMI and COPD combined with osteoporosis. Three studies data were included in the study; The results of the meta-analysis showed that: OR = 0.30; 95% CI: 0.27–0.34; I 2= 9%, P <0.00001; The results of the final analysis study showed that BMI is a risk factor for comorbid osteoporosis in COPD patients.
BMI and risk factors for stroke combined with osteoporosis
Two case-control studies (Wang Kai et al., 2020; Li HuiLan et al., 2008) explored the association between BMI and stroke combined with osteoporosis. Meta-analysis results show: I 2=96%, heterogeneity is large, so it cannot indicate that BMI is related to risk factors for stroke combined with osteoporosis, Plural analysis of the literature: Results of a literature (Wang Kai et al., 2020) analysis shows that low BMI is a risk factor for stroke combined with osteoporosis (OR=2.427, P=0.043); An analysis of the literature (Li HuiLan et al., 2008) shows that low BMI is a risk factor for stroke combined with osteoporosis (OR=0.75, P<0.01).
Publication Bias:
Because the number of papers included in each study did not exceed seven, no test of publication bias was given.